Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

559 ARTÍCULOS , VIENDO DEL 436 AL 450

Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial

Edwards AL, Collins JA, Junge C, Kordasiewicz H, Mignon L, Wu S, Li Y, Lin L, DuBois J, Hutchison RM, Ziogas N, Shulman M, Martarello L, Graham D, Lane R, Budd Haeberlein S, Beaver J.

JAMA Neurol. 2023 Dec 1;80(12):1344-1352. doi: 10.1001/jamaneurol.2023.3861.

The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Wu W, Ji Y, Wang Z, Wu X, Li J, Gu F, Chen Z, Wang Z.

Eur J Med Res. 2023 Nov 28;28(1):544. doi: 10.1186/s40001-023-01512-w.

Recent Insights on Glutamatergic Dysfunction in Alzheimer's Disease and Therapeutic Implications

Pinky PD, Pfitzer JC, Senfeld J, Hong H, Bhattacharya S, Suppiramaniam V, Qureshi I, Reed MN.

Neuroscientist. 2023 Aug;29(4):461-471. doi: 10.1177/10738584211069897. Epub 2022 Jan 25.

Therapeutic role of curcumin in adult neurogenesis for management of psychiatric and neurological disorders: a scientometric study to an in-depth review

Ma W, Xu D, Zhao L, Yuan M, Cui YL, Li Y.

Crit Rev Food Sci Nutr. 2023;63(28):9379-9391. doi: 10.1080/10408398.2022.2067827. Epub 2022 Apr 28.

The therapeutic potential of the neuroactive peptides of soluble amyloid precursor protein-alpha in Alzheimer's disease and related neurological disorders

Mockett BG, Ryan MM.

Semin Cell Dev Biol. 2023 Apr;139:93-101. doi: 10.1016/j.semcdb.2022.05.014. Epub 2022 May 30.

Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials

Langbaum JB, Zissimopoulos J, Au R, Bose N, Edgar CJ, Ehrenberg E, Fillit H, Hill CV, Hughes L, Irizarry M, Kremen S, Lakdawalla D, Lynn N, Malzbender K, Maruyama T, Massett HA, Patel D, Peneva D, Reiman EM, Romero K, Routledge C, Weiner MW, Weninger S, Aisen PS.

Alzheimers Dement. 2023 Feb;19(2):696-707. doi: 10.1002/alz.12737. Epub 2022 Aug 10.

Natural remedies for Alzheimer's disease: A systematic review of randomized controlled trials

Ahmad S, Ahmed SB, Khan A, Wasim M, Tabassum S, Haider S, Ahmed F, Batool Z, Khaliq S, Rafiq H, Tikmani P, Gilani AU.

Metab Brain Dis. 2023 Jan;38(1):17-44. doi: 10.1007/s11011-022-01063-9. Epub 2022 Aug 12.

Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments

Seyedaghamiri F, Rajabi M, Mohaddes G.

Neurochem Res. 2023 Jan;48(1):26-38. doi: 10.1007/s11064-022-03734-6. Epub 2022 Sep 1.

An insight into the neuroprotective effects and molecular targets of pomegranate (Punica granatum) against Alzheimer's disease

George N, AbuKhader M, Al Balushi K, Al Sabahi B, Khan SA.

Nutr Neurosci. 2023 Oct;26(10):975-996. doi: 10.1080/1028415X.2022.2121092. Epub 2022 Sep 20.

Development of new Alzheimer's disease drug candidates using donepezil as a key model

Eissa KI, Kamel MM, Mohamed LW, Kassab AE.

Arch Pharm (Weinheim). 2023 Jan;356(1):e2200398. doi: 10.1002/ardp.202200398. Epub 2022 Sep 23.

The effects of fenugreek seed extract supplementation in patients with Alzheimer's disease: A randomized, double-blind, placebo-controlled trial

Foroumandi E, Javan R, Moayed L, Fahimi H, Kheirabadi F, Neamatshahi M, Shogofteh F, Zarghi A.

Phytother Res. 2023 Jan;37(1):285-294. doi: 10.1002/ptr.7612. Epub 2022 Oct 5.

Relieving care burden and promoting health-related quality of life for family caregivers of elderly people with Alzheimer's disease via an empowerment program

Yazdanmanesh M, Esmaeili R, Nasiri M, Vasli P.

Aging Clin Exp Res. 2023 Jan;35(1):73-83. doi: 10.1007/s40520-022-02277-8. Epub 2022 Oct 25.

Lycopene: Sojourn from kitchen to an effective therapy in Alzheimer's disease

Kapoor B, Gulati M, Rani P, Kochhar RS, Atanasov AG, Gupta R, Sharma D, Kapoor D.

Biofactors. 2023 Mar;49(2):208-227. doi: 10.1002/biof.1910. Epub 2022 Nov 1.

Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease

Lane HY, Wang SH, Lin CH.

Psychiatry Clin Neurosci. 2023 Feb;77(2):102-109. doi: 10.1111/pcn.13504. Epub 2022 Nov 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias